We are live on ! Find out more
AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

4 hedge funds and large institutions have $57.6K invested in Amedisys in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 315 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 3194 (-315)

99.1% less ownership

Funds ownership: 99.1%0% (-99%)

99% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 315

100% less funds holding in top 10

Funds holding in top 10: 60 (-6)

100% less capital invested

Capital invested by funds: $3.2B → $57.6K (-$3.2B)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
4
Holders Change
-315
Holders Change %
-98.75%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-100%
% of All Funds
New
2
Increased
Reduced
2
Closed
315
Calls
Puts
Net Calls
Net Calls Change

AMED Hedge Fund Activity: Q3 2025 in Review

4 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q3 2025, worth a combined $57.6K — down 100% from $3.2B a quarter earlier.

Sellers outnumbered buyers: 315 funds closed out of AMED and 2 opened new positions — a net loss of 313 holders — while 2 trimmed existing stakes and 0 added.

The largest buyer was IFP Advisors, opening a new position worth an estimated $7.08K. The largest seller was BlackRock, exiting entirely with an estimated $329M sold.

  • 4 institutional investors held Amedisys (AMED) as of Q3 2025, down from 319 in Q2 2025.
  • Funds reported $57.6K of Amedisys stock for Q3 2025, down 100% quarter-over-quarter.
  • 2 funds opened new Amedisys positions in Q3 2025 and 315 closed out, a net change of -313 holders.
  • The largest Amedisys buyer in Q3 2025 was IFP Advisors, an estimated $7.08K added.
  • The largest Amedisys seller in Q3 2025 was BlackRock, an estimated $329M sold.

Based on aggregated 13F filings for Q3 2025.